Yea trials always seem to drag on a bit.
Recce's (RCE) phase 1 clinical trial for IV dosing has been going for about 10 months now, although more cohorts than AGN's trial.
If dosing begins in a month from now, I'd anticipate results around mid-2023.
Ann: Phase 1 Clinical Trial Summary, page-6
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
76.0¢ |
Change
0.020(2.70%) |
Mkt cap ! $97.35M | |||
| Open | High | Low | Value | Volume |
| 73.5¢ | 76.0¢ | 72.3¢ | $96.97K | 130.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 73.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 76.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.40pm 27/09/2024 (20 minute delay) ? |
| AGN (ASX) Chart |